Efficacy and Safety of Anticoagulation on Patients With Cirrhosis and Portal Vein Thrombosis María Gabriela Delgado, Susana Seijo, Ismael Yepes, Linette Achécar, Maria Vega Catalina, Ángeles García–Criado, Juan G. Abraldes, Joaquín de la Peña, Rafael Bañares, Agustín Albillos, Jaume Bosch, Juan Carlos García–Pagán Clinical Gastroenterology and Hepatology Volume 10, Issue 7, Pages 776-783 (July 2012) DOI: 10.1016/j.cgh.2012.01.012 Copyright © 2012 AGA Institute Terms and Conditions
Figure 1 Radiologic response: rate of complete and partial recanalization, and no response to anticoagulation therapy. This figure also describes the median time each group received anticoagulation treatment. Clinical Gastroenterology and Hepatology 2012 10, 776-783DOI: (10.1016/j.cgh.2012.01.012) Copyright © 2012 AGA Institute Terms and Conditions
Figure 2 Radiologic outcome after discontinuation of anticoagulation treatment and median time from anticoagulation discontinuation to radiologic imaging. Clinical Gastroenterology and Hepatology 2012 10, 776-783DOI: (10.1016/j.cgh.2012.01.012) Copyright © 2012 AGA Institute Terms and Conditions